|
|
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
First published online January 19, 2006
Journal of Experimental Biology 209, 531-540 (2006)
Published by The Company of Biologists 2006
doi: 10.1242/jeb.02011
The neuropeptide proctolin potentiates contractions and reduces cGMP concentration via a PKC-dependent pathway
Department of Biology, University of Konstanz, 78457 Konstanz, Germany
* Author for correspondence (e-mail: s.kreissl{at}uni-konstanz.de)
Accepted 22 November 2005
As in many other arthropods, the neuropeptide proctolin enhances contractures of muscles in the crustacean isopod Idotea emarginata. The enhancement of high K+-induced contractures by proctolin (1 µmol l-1) was mimicked upon application of the protein kinase C (PKC) activator phorbol-12-myristate 1-acetate (PMA) and was inhibited by the PKC inhibitor bisindolylmaleimide (BIM-1). The potentiation was not inhibited by H89, a protein kinase A (PKA) inhibitor. Proctolin did not change the intracellular concentration of 3',5'-cyclic adenosine monophosphate (cAMP) whereas it significantly reduced the intracellular concentration of 3',5'-cyclic guanosine monophosphate (cGMP). The reduction of cGMP was not observed in the presence of the PKC inhibitor BIM-1. 8-Bromo-cGMP, a membrane-permeable cGMP analogue, reduced the potentiating effect of proctolin on muscle contracture. We thus conclude that proctolin in the studied crustacean muscle fibres induces an activation of PKC, which leads to a reduction of the cGMP concentration and, consequently, to the potentiation of muscle contracture.
Key words: Idotea emarginata, neuropeptide, modulation, cAMP, cGMP, PKC, PKA
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
Related articles in JEB:
This article has been cited by other articles:
![]() |
K. Phillips PROCTOLIN MEDIATES EFFECT THROUGH cGMP J. Exp. Biol., February 1, 2006; 209(3): ii - ii. [Full Text] [PDF] |
||||